Treatment Of Ssc-Ild In 2020 - Dr. Shane Shapera

Treatment of SSc-ILD in 2020 - Dr. Shane Shapera

The Canadian Pulmonary Fibrosis Foundation

Advances in Myositis Associated Lung Disease Treatment - Dr Shane Shapera

The Canadian Pulmonary Fibrosis Foundation

Interstitial Lung Disease: Dr. Shane Shapera

Scleroderma Canada

Dr. Shane Shapera – Lung Cancer in ILD patients: A Serious Growing Problem

The Canadian Pulmonary Fibrosis Foundation

Therapies for IPF, from Pills to Lung Transplantation with Dr. Shane Shapera and Dr. Shaf Keshavjee

The Canadian Pulmonary Fibrosis Foundation

SSc ILD Anti acid Therapy Treatment

The France Foundation

SSc-ILD Care: Expert Strategies for Diagnosis, Treatment, and Managing Comorbidities

Interim Analysis of SENSCIS ON TRIAL for SSc ILD Patients Treated with Nintedanib

The France Foundation

Dr. Shane Shapera - Supporting the First Generation of ILD Trained Clinicians in Canada

The Canadian Pulmonary Fibrosis Foundation

The Power of Interprofessional Teams in SSc-ILD: From Diagnosis Through Management

How I Think, How I Treat – Contemporary Insights on Diagnosing and Managing SSc-ILD

What is SSc-ILD? Systemic Sclerosis Associated Interstitial Lung Disease #ild #pulmonaryfibrosis

Interstitial Lung Disease Info

Updates in SSc-ILD Management

The France Foundation

SSc-ILD: Expert Insights on Current Management and Emerging Therapy

SSc ILD Progress in Diagnosis and Treatment

The France Foundation

Monitoring for Changes in Disease Course and Comorbidities in SSc ILD

The France Foundation

Lung disease in scleroderma (systemic sclerosis associated interstitial lung disease)

Dr. Stefan Cristian Stanel

Biochemical Profiles of Radiographic Patterns in SSc ILD

The France Foundation

Lungs&You Couch Talk: Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

CYC for SSc-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II

The Journal of Rheumatology